Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Leukemia & Lymphoma
|
June 3, 2017
Acute myeloid leukemia in the elderly: therapeutic options and choice
Jonathan A Webster, Keith W Pratz
Frontiers in Oncology
|
January 3, 2022
Treatment of AML Relapse After Allo-HCT
Jonathan A Webster, Leo Luznik, Ivana Gojo
NPJ Digital Medicine
|
July 16, 2021
Mobile app validation: a digital health scorecard approach
Ramy Sedhom, Michael J McShea, Adam B Cohen, et al.
AJSP: Reviews & Reports
|
July 14, 2020
B-Lymphoid Blast Phase of Chronic Myeloid Leukemia: A Case Report and Review of the Literature
Alisha D Ware, Laura Wake, Patrick Brown, et al.
Clinical and Translational Science
|
June 22, 2023
DNA methyltransferase inhibitor exposure-response: Challenges and opportunities
Amanda B Kagan, Dominique A Garrison, Nicole M Anders, et al.
Leukemia Research
|
November 12, 2021
A randomized, phase II trial of adjuvant immunotherapy with durable TKI-free survival in patients with chronic phase CML
Jonathan A Webster, Tara M Robinson, Amanda L Blackford, et al.
The Journal of Pathology
|
July 2, 2010
Variations in stromal signatures in breast and colorectal cancer metastases
Jonathan A Webster, Andrew H Beck, Mimansa Sharma, et al.
Leukemia & Lymphoma
|
July 21, 2021
A phase II study of azacitidine in combination with granulocyte-macrophage colony-stimulating factor as maintenance treatment, after allogeneic blood or marrow transplantation in patients with poor-risk acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS)
Jonathan A Webster, Meera Yogarajah, Marianna Zahurak, et al.
Ejhaem
|
October 17, 2024
A phase 1 trial of venetoclax in combination with liposomal vincristine in patients with relapsed or refractory B-cell or T-cell acute lymphoblastic leukemia: Results from the ECOG-ACRIN EA9152 protocol
Neil D Palmisiano, Ju-Whei Lee, David F Claxton, et al.
Leukemia & Lymphoma
|
February 15, 2026
Chemotherapy regimens with second generation tyrosine kinase inhibitors for <i>BCR-ABL</i> B-cell acute lymphoblastic leukemia: comparative outcomes and role of allogeneic hematopoietic cell transplantation
John Preston Claiborne, Hua-Ling Tsai, Gabriel Ghiaur, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Leukemia & Lymphoma
|
June 3, 2017
Acute myeloid leukemia in the elderly: therapeutic options and choice
Jonathan A Webster, Keith W Pratz
Frontiers in Oncology
|
January 3, 2022
Treatment of AML Relapse After Allo-HCT
Jonathan A Webster, Leo Luznik, Ivana Gojo
NPJ Digital Medicine
|
July 16, 2021
Mobile app validation: a digital health scorecard approach
Ramy Sedhom, Michael J McShea, Adam B Cohen, et al.
AJSP: Reviews & Reports
|
July 14, 2020
B-Lymphoid Blast Phase of Chronic Myeloid Leukemia: A Case Report and Review of the Literature
Alisha D Ware, Laura Wake, Patrick Brown, et al.
Clinical and Translational Science
|
June 22, 2023
DNA methyltransferase inhibitor exposure-response: Challenges and opportunities
Amanda B Kagan, Dominique A Garrison, Nicole M Anders, et al.
Leukemia Research
|
November 12, 2021
A randomized, phase II trial of adjuvant immunotherapy with durable TKI-free survival in patients with chronic phase CML
Jonathan A Webster, Tara M Robinson, Amanda L Blackford, et al.
The Journal of Pathology
|
July 2, 2010
Variations in stromal signatures in breast and colorectal cancer metastases
Jonathan A Webster, Andrew H Beck, Mimansa Sharma, et al.
Leukemia & Lymphoma
|
July 21, 2021
A phase II study of azacitidine in combination with granulocyte-macrophage colony-stimulating factor as maintenance treatment, after allogeneic blood or marrow transplantation in patients with poor-risk acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS)
Jonathan A Webster, Meera Yogarajah, Marianna Zahurak, et al.
Ejhaem
|
October 17, 2024
A phase 1 trial of venetoclax in combination with liposomal vincristine in patients with relapsed or refractory B-cell or T-cell acute lymphoblastic leukemia: Results from the ECOG-ACRIN EA9152 protocol
Neil D Palmisiano, Ju-Whei Lee, David F Claxton, et al.
Leukemia & Lymphoma
|
February 15, 2026
Chemotherapy regimens with second generation tyrosine kinase inhibitors for <i>BCR-ABL</i> B-cell acute lymphoblastic leukemia: comparative outcomes and role of allogeneic hematopoietic cell transplantation
John Preston Claiborne, Hua-Ling Tsai, Gabriel Ghiaur, et al.
Page
of 3